B2B for psychiatrists, developmental pediatricians, and therapists — a ready clinical workflow. Observa Care is our B2C product parents can use today for personalized neurodevelopmental support. Observa Screen is our R&D track on biomarkers for autism detection — rigorous science, not a consumer toy.
Confidential access: NDA & intake →
Observa Care is our mature consumer-facing product for families. Our B2B offering is ready for psychiatrists, developmental pediatricians, and therapists who want structured workflows in practice. Observa Screen is the research line — serious work on biomarkers for autism detection, not a lightweight parent app.
Deploy Observa inside your clinic or network: structured developmental intake, AI-supported care planning, and optional integration with our screening R&D where appropriate for your protocol.
Observa Care is our polished B2C experience — guided assessment, evidence-grounded answers, and progressive therapy-style plans families can actually follow between visits.
Observa Screen is where we invest in objective signals — gaze, attention, and behaviour-derived features for autism detection and differentiation. This line is research-forward: protocols, norms, and validation come before any broad consumer claim.
"We knew something was different when he was 18 months. We finally got a diagnosis at age 4. Two years of early intervention window — gone."
The problem isn't awareness — it's the infrastructure gap between concern and action.
Clinics use subjective questionnaires designed in the 1980s. Parents get
a score sheet with no guidance. And early intervention — proven to be most
effective before age 4 — is squandered in paperwork and waitlists.
Observa closes that gap.
Observa Care is our flagship B2C assistant — the solid product parents can rely on. The same stack powers B2B deployments for psychiatrists, developmental pediatricians, and therapists. Observa Screen is our dedicated R&D surface for autism-detection biomarkers and objective screening science.
Our research program on biomarkers for autism detection — structured stimuli, gaze and behaviour-derived features, and rigorous validation paths. Meant for R&D partnerships with clinics and academic collaborators, not as a casual consumer download.
Our B2C product for parents — an agentic neurodevelopmental assistant with structured assessment and RAG over curated therapy content, producing actionable 4-week plans. Psychiatrists, pediatricians, and therapists can deploy the same capability in B2B settings for triage, education, and between-visit support.
Clinician runs the structured questionnaire or parent completes it at home. Takes 10–15 minutes.
Child watches standardized stimuli on screen. Webcam captures gaze and behavior. No special hardware.
Computer vision models extract biomarkers. Claude AI synthesizes profile, DQ scores, and priority areas.
Family receives a full 4-week therapy plan with daily activities, parent coaching notes, and progress markers.
Our AI generates structured, evidence-based 4-week plans — not bullet points. Each plan includes daily activities, parent coaching scripts, progress checkpoints, and escalation criteria.
A practicing child psychiatrist, a computer vision engineer, and a product & growth operator — all working the same problem from different angles.
Child & adolescent psychiatrist and Assistant Professor at JNU Medical College, Jaipur. 25 indexed publications, 80+ citations, and editor of a statistics textbook. Built the full neurodevelopmental AI chatbot — speech recognition, LLM integration, and the agentic LangGraph pipeline. Authored Observa's proprietary CBT, MET & DBT-informed clinical knowledge base. Active pilot network of 4–5 doctors.
Computer vision and ML engineer based in Atlanta. Leads the full technical build — video-analysis pipeline, backend systems, and product infrastructure. Georgia Tech idea-to-prototype program alumnus. Full-stack ownership from architecture to deployment.
Leads computer vision engineering and the agentic LangGraph architecture that powers Observa's multi-step reasoning pipeline. Brings deep systems thinking to the intersection of CV models and orchestrated AI agents — making the platform fast, reliable, and clinically coherent end-to-end.
Request access to protected pilots and materials (e.g. advanced product demos, R&D previews). We use DocuSign for mutual NDAs: you receive an envelope at your work email, sign in DocuSign, then complete the intake below. We verify completion before sharing links or credentials.
Confidential Information includes software behaviour, prompts, instrument logic, unpublished methods, pilot data, and business plans. You agree to hold it in strict confidence, use it only for the agreed evaluation, not copy or disclose except to advisors under similar duties, and return or destroy materials on request.
If this summary conflicts with your countersigned NDA PDF, the PDF controls.
Legal disclaimer: This page describes process and expectations only. The binding agreement is the fully executed mutual NDA as shown in your DocuSign account (envelope status, audit trail, certificate of completion) and the countersigned PDF you download — not marketing copy on this site alone.
Need the NDA or a DocuSign envelope? Email gauravm2404@gmail.com with subject line Observa NDA / DocuSign.
Use this as an implementation punch list. Store all IDs and keys outside this HTML (environment variables or a secrets manager only).
YOUR_DOCUSIGN_TEMPLATE_ID). Confirm how envelopes are created from it (REST POST /envelopes with templateId, or equivalent SDK call).DOCUSIGN_* variables). Rotate keys if exposed.envelope-completed (and voided/expired if needed) to update internal records instead of only checking the dashboard.nda-access intake can be matched to that envelope (automated or manual).After your DocuSign envelope is completed (or you have countersigned wet ink as we directed), submit this intake. Submissions are delivered via Netlify Forms.
This form does not call the DocuSign API; our team matches your intake to your completed DocuSign envelope (or wet-ink file) before granting access.
We're looking for B2B partners — psychiatrists, developmental pediatricians, and therapists — for our pilot cohort, plus investors who believe AI can close the autism diagnosis gap. Parents exploring Observa Care are welcome too.
Or email us directly: gauravm2404@gmail.com · raghavanmadabushi10@gmail.com